Category: Amylin Analogue / Weight Management Peptide

Cagrilintide is a synthetic, long-acting amylin analogue currently being researched for its role in appetite regulation, weight management, and metabolic health. As a once-weekly investigational compound, Cagrilintide works synergistically with GLP-1 receptor agonists to enhance satiety, reduce food intake, and support bodyweight reduction.

With a 10mg vial, this peptide is ideal for advanced research into novel therapies for obesity, type 2 diabetes, and metabolic syndrome. Cagrilintide mimics the natural hormone amylin, which is co-secreted with insulin from pancreatic β-cells, helping regulate gastric emptying, appetite, and energy balance.

Key Features:

• 10mg high-purity research vial

• Long-acting amylin analogue

• Enhances satiety and reduces caloric intake

• Synergistic potential with GLP-1 receptor agonists (e.g., Semaglutide, Tirzepatide, Retatrutide)

• Research focus: weight management, diabetes, and metabolic health

CAS Number: 1802072-41-4

Disclaimer:
Cagrilintide 10mg is supplied for research use only. It is not a medicine and is not intended for human consumption.